Циторедуктивные операции и гипертермическая внутрибрюшинная химиотерапия в комплексном лечении распространенных форм интраабдоминального рака
Диссертация
Проблема карциноматоза брюшины до сих пор остается актуальной при лечении дигестивного и овариального рака. Наличие перитонеального карциноматоза является неблагоприятным фактором прогноза выживаемости больных (Chu D.Z. et al., 1989; Eltabbakh G.H. et al., 1998; Blair S.L. et al., 2001). При первичной операции у 10−20% больных с дигестивным раком обнаруживают диссеминацию опухоли по брюшине… Читать ещё >
Список литературы
- Автандилов Г. Г. Компьютерная микротелефотометрия вдиагностической гистоцитопатологии. М.: РМАПО, 1996. — 256 с.
- Аксель Е.М., Давыдов М. И. Заболеваемость и смертность от злокачественных новообразований: Россия, 2000 год// Злокачественные новообразования в России и странах СНГ в 2000. М.: РОНЦ им. Н. Н. Блохина РАМН, 2002. — С.85−106.
- Багненко С.Ф., Рухляда Н. В., Гринев М. В., Беляев A.M. Лечение карциноматоза брюшины негинекологического происхождения // Вестн. хирургии. 2000. — Том 161, № 6. — С. 94−99.
- Беришвили А.И., Кузнецов В. В., Горбунова В. А., Блюменберг А. Г. Хирургическое лечение рака яичников III-IV стадии // Вестн. хирургии. 2002. — Том 161, № 1. — С. 48−50.
- Блохин Н.Н., Трапезников Н. Н., Переводчикова Н. И., Цыб А.Ф., Бердов Б. А. Перспективы лечения местнораспространенных и диссеминированных опухолей // Большая мед. энциклопедия. 3-е изд. — М.: Советсткая энциклопедия. — 1988. — Т.29. — С. 173- 179.
- Габриелян М.А. Комбинированное лечение аденокарцином желудка и толстой кишки в условиях общехирургического отделения: Автореф. дис. канд. мед. наук. СПб, 2003. -23 с.
- Гарин A.M. Химиотерапия диссеминированного рака ободочной кишки, очередность назначения цитостатиков // Практ. онкол. -2000.-№ 1.-С. 27−30.
- Гринев М.В. Оправдана ли циторедуктивная хирургия в лечении колоректального рака IV стадии // Вопр. онкол.—2000.— № 1. С. 107−111.
- Гринев М.В. Циторедуктивная хирургия как альтернатива паллиативным операциям в онкологии (на модели леченияколоректального рака IV стадии) // Вестн. хирургии. 2002. — Том 161, № 6.- С. 100−103.
- Гринев М.В. Циторедуктивная хирургия на модели лечения колоректального рака IV стадии. СПб: Гиппократ, 2003. — 92 с.
- Гринев М.В., Беляев A.M., Карачун Р. В. Алгоритм лечения запущенных и осложненных форм колоректального рака (пособие для врачей) СПб НИИ им. И. И. Джанелидзе. 2003. — 12 с.
- Горбунова В.А. Химиотерапия рака яичников // РМЖ. 2001.-Том.9, № 22 (141). — С.974−978.
- Громов М. С, Александров Д. А., Кулаков А. А., Самедов И. А. Диагностика и лечение распространенного рака желудка // Хирургия. 2003. — № 4. — С.20−23.
- Гланц С. Медико-биологическая статистика. Пер. с англ. М., Практика, 1999.-459 с.
- Давыдов М.И., Тёр-Ованесов М.Д. Современная стратегия хирургического лечения рака желудка // Совр. онкол. 2000. — № 1. -С. 4−10.
- Давыдов М.И., Тёр-Ованесов М.Д., Абдихакимов А. Н., Марчук В. А. Рак желудка: что определяет стандарты хирургического лечения // Практ. онкол. № 3(7). — 2001. — С. 18−24.
- Давыдов М.И., Тер-Ованесов М.Д., Абдихакимов А. Я., Марчук В. А. Рак желудка: предоперационное обследование и актуальные аспекты стадирования // Практ онкол. № 3(7). — 2001. — С. 9−17.
- Давыдов М.И., Абдихакимов А. Н., Плоцкий Б. Е., Стилиди И. С., Тёр-Ованесов М.Д., Марчук В. А. К вопросу о роли хирургии в лечении местнораспространенного и диссеминированного рака желудка // Анн. хир. 2002. — № 2. — С.33−41.
- Ермакова Е.А., Моисеенко В. М., Орлова Р. В. Диагностика и выбор лечебной тактики у больных первичными и метастатическими опухолями яичников // Вопр. онкол.—2001.— том 47, № 1. С. 9599.
- Жорданиа К.И. Некоторые аспекты хирургического лечения рака яичников // Практ. онкол. № 4. — 2000. — С. 19−24.
- Казаченко В.П. Диагностика и лечение рака яичников // Гинекология. 1999. — № 2. — С.39−42.
- Краткое руководство по диагностике и стадированию рака в развитых и развивающихся странах. (Пер. и ред.проф. Е. Н. Блинова, М.М.Константиновой).- СПб: СОТИС, 2001.- 198 с.
- Малиновский Н.Н., Северцев А. Н., Смирнова Н. Б. Циторедуктивная хирургия метастазов колоректального рака в печени: принципы и интраартериальная регионарная химиотерапия // Хирургия. 2003. -№ 3.-С. 14−21.
- Мартынюк В.В. Рак ободочной кишки (заболеваемость, смертность, факторы риска, скрининг) // Практ. онкол. — 2000. -№ 1. -3−9.
- Меребишвили В.М. рак желудка: эпидемиология, профилактика, оценка эффективности лечения на популяционном уровне // Практ. онкол. 2001.- № 3(7). — С. 3−8.
- Моисеенко В.М., Волков О. Н. Симптоматическая терапия больных распространенным раком ободочной кишки // Практ. онкол. 2000. -№ 1.-С. 38−42.
- Нариманов М.Н., Базин И. С., Мамедов Ф. Ф., Ефимов О. Н., Трякин А. А. и др. Три режима химиотерапии диссеминированного колоректального рака // Совр. онкол. 2001. — Том 3, № 4. — С. 7479.
- Нечаева И.Д. Опухоли яичников. JL: Медицина, 1987. — 208 с.
- Новикова Е.Г., Ронина Е. А., Корнеева И. А. Современные подходы в лечении злокачественных опухолей яичников. Мат. научн.-практ. конф. «Новые подходы к скринингу, диагностике и лечению опухолей яичников» В. Новгород, 2001. — СПб, 2001. — С. 110.
- Орлова Р.В. Современное стандартное лечение раком яичников // Практ. онкол. 2000. — № 4. — С. 42−43.
- Патютко Ю.И., Черкес B.JL, Ананьев B.C. Лечение распространенных форм колоректального рака // Рак ободочной и прямой кишки.— М.: Медицина, 1997. С. 259−267.
- Патютко Ю.И., Сагайдак И. В. Современные подходы к лечению при метастатическом поражении печени убольных колоректальным раком // Новое в терапии колоректального рака.— М., 2001.— С. 49−52.
- Переводчикова Н.И. Химиотерапия колоректального рака // РМЖ.- 2001. Том 9, № 22(141). — С. 968−974.
- Привалов А.В., Важенин А. В. Осложнения комбинированного лечения рака желудка // Вопр. онкол.- 2003. Том 49, № 1. — С.88−92.
- Савина И.А., Моисеенко В. М., Васильев С. В., Симонов Н. Н. Показатели выживаемости больных раком ободочной кишки с отдаленными метастазами после операций различного объема // Вопр.онкол. 2003. -Том 49, № 3. — С. 340−346.
- Симонов Н.Н., Гуляев А. В., Правосудов И. В., Халтурин В. Ю., Мельников О. Р., Ананьев Н. В., Чарторижский В. Д. Приоритетные направления и перспективы в лечении рака желудка // Вопр. онкол.- 1998. том 44, № 2. — С. 246−250.
- Симонов Н.Н., Правосудов И. В., Гуляев А. В., Халтурин В. Ю., Ушверидзе Д. Г. Современные принципы хирургического лечения рака ободочной кишки // Практ. онкол. — 2000. № 1. — С. 14−18.
- Симонов Н.Н. Хирургическое лечение рака прямой кишки при наличии отдаленных метастазов. Циторедуктивные, паллиативные, симптоматические операции // Практ. онкол. 2002. — № 2(3). — С. 130−135.
- Тарасов В.А., Виноградова М. В., Ключиков В. З., Беляев A.M. Хирургическое лечение распространенных форм рака желудка // Практ. онкол. 2001. — № 3(7). — С. 52−58.
- TNM Классификация злокачественных опухолей (перевод Н.Н.Блинова): шестое издание. СПб: ЭСКУЛАН, 2003.- 244 с.
- Урманчеева А.Ф. Эволюция терапии рака яичника // Вопр. онкол. — 2002. Том 48, № 4−5. — С.536−543.
- Фролова С.А., Репина Н. Н., Недосекина В. В. О результатах оперативного лечения больных распространенным раком яичников.- Мат. науч. конф. «Новые подходы к скринингу, диагностике и лечению опухолей яичников» В. Новгород, 2001. — СПб., 2001. -С.111.
- Химиотерапия опухолевых заболеваний. Под ред. Н. И. Переводчиковой. М: б.и., 2000. — 392 с.
- Чиссов В.И., Авербах A.M. Адъювантная внутрибрюшинная химиотерапия при радикальном и паллиативном лечении рака желудка // Хирургия. 1999. — № 1. — С.61−65.
- Abulafi A.M., Williams N.S. Local recurrence of colorectal cancer: the roblem, mechanisms, management and adjuvant therapy // Brit. J. Surg. 1994.-Vol. 81.-P. 7−19.
- Akiyama H., Yamaoka H., Tanaka K. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer // Hepatogastroenterology. 1998. — Vol. 45, № 24. — P 2079−2086.
- Armour E.P., McEachern D., Wang Z., Corry P.M. Sensitivity of human cells to mild hyperthermia // Cancer Res. 1993. — Vol.53. — P. 2740 -274 4.
- Averbach A.M., Sugarbaker P.H. Methodologic considerations in treatment using intraperitoneal chemotherapy//Peritoneal canceromatosis: Principles of management Ed by P.H.Sugarbaker. -New York: Kluwer Academic Publishers- Boston. 1996. — P. 289−309.
- Bae B.J., Park K.H., Sohn S.S. Prognosis of the patients with stage IV gastric cancer in Siewert J. R, Roder J.D. (eds): 2nd International Gastric Cancer Congress. -Bologna, Monduzzi, 1997. P. 175−179.
- Baradi H., Ponsky J. Pseudomyxoma peritonei // Surgery. 2002. -Vol. 131(2).-P. 230−231.
- Beaujard A.C., Francois Y., Glehen 0. Intraperitoneal chemohyperther-mia with mitomycin С in gastric cancer patients with peritoneal carcinomatosis // Ancicancer Res. 1999. — Vol.19. — P. 1375−1382.
- Beaujard A.C., Glehen 0., Caillot J.L. Intraperitoneal chemohyperthermia with mitomycin С for digestive tract cancer 'with peritoneal carcinomatosis // Cancer. 2000. — Vol. 88. — P.2512−2519.
- Benoit L., Duvillard C., Rat P. Effects de la temperature intra-abdominale sur la diffuion tissulaire et tumorale du cisplatine iniraperitoneal dansun modele de carcinose perito-neale chez // Ie rat. Chirurgie. 1999. — Vol.124. — P. 375−379.
- Benson A.B. Therapy for advanced colorectal cancer // Sem. Oncol. -1998.-Vol.25.-P. 2−11.
- Berny C., Mialon A., Manchon M., Le K.E. Biochemical modifications in the blood and the heated fluids during intraperitoneal chemohyperthermia // Oncology. -1993. Vol. 50, № 5. — P. 362−365.
- Berthet В., Sugarbaker T.A., Chang D. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment // Europ. J. Cancer. 1999. — Vol.35, № 3. — P.413−419.
- Bergman C., Boente M. Surgery for gynecologic malignancies. // Curr. Opin. Oncol. 1998. — Vol.10, № 5. — P. 434−8.
- Blair S.L., Chu D.Z., Schwarz R.E. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer // Ann. Surg. Oncol. 2001. — Vol. 8, № 8. — P. 632−637.
- Bonenkamp J.J., Songun I., Hermans J., Sasako M., van de Velde C.J. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients // Lancet.-1995.- Vol. 8952. P. 745−748.
- Bozetti F., Bonfanti G., Morabito A. A multifactirial approach for the prognosis of patients with carcinoma of the stomach after the curative resection// Surg. Gynecol. Obstet. 1986. — Vol. 162. — P. 229−234.
- Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., Karlan B.Y. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. // Gynecol. Oncol. 1999. — Vol. 72, № 3. — P. 278−287.
- Bristow R.E., Gossett D.R., Shook D.R., Zahurak M.L., Tomacruz R.S. Armstrong D.K., Montz. F.J. Recurrent micropapillary serous ovarian carcinoma // Cancer. -2002. Vol. — 15, № 95(4). — P.791−800.
- Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis // J. Clin. Oncol. -2002. Vol. 1,№ 20(5). — P. 1248−1259.
- Brodsky J.T., Cohen A.M. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy // Dis. Colon Rectum. 1991. — Vol.34. — P.723−727.
- Brundell S.M., Tucker К., Chatterton В., Hewett P.J. The effect of lavage on intraabdominal cell burden // Surg. Endosc. 2002. — Vol. — 16, № 7. — P. 1064−1067.
- Buell J.F., Bartlett D.L., Venson D.J. Continuous hyperthermic peritoneal perfusion (CHPP) with TNF and cisplatin for the treatment of peritoneal carcinomatosis: Society of Surgical Oncology 49th Annual Meeting. -Atlanta, GA, USA, 1996. P.77.
- Butterworth S.A., Panton O.N., Klaassen D.J., Shah A.M., McGregor G.I. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei // Amer. J. Surg. 2002. — Vol.183, № 5. — P. 529 532.
- Cavaliere F., Di Filippo F., Botti C. Peritonectomy and hyperthermic antiblastic pernision in the treatment of peritoneal Carcinomatosis // Europ. J. Surg. Oncol. 2000. — Vol. 26. — P. 486−591.
- Cavaliere F., Perri P., Di Filippo F. Treatment of peritoneal carcinomatosis with intent to cure // J. Surg. Oncol. 2000. — Vol.74. -P.41 -44.
- Ceelen W.P., Hesse U., Hemptinne В., Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer // Brit. J. Surg. 2000. — Vol.87. — P. 10 061 015.
- Cho S. J., Lee H. K., Kim Y.H. Survival analysis of the palliatively resected gastric carcinoma: Proceeding of the 4h International Gastric Cancer Congress Gastric Cancer Congress. New-York, USA, 2001. — P.289.
- Christophi C., Winkworth A., Muralihdaran V. The treatment of malignancy by hyperthermia // Surg. Oncol. 1999. — Vol. 7. — P. 83−90.
- Chu D.Z., Lang N.P., Thompson C., Osteen P.K., Westbrook K.C. Pertioneal carcinomatosis in nongynecologic malignancy: A prospective study of prognostic factors // Cancer. 1989. — Vol. 63. — P. 364−367.
- Clark J.W. Perspectives on new chemotherapeutic agents in the treatment of colorectal cancer // Sem. Oncol. -1997. Vol.24, № 18. -P. 18−24.
- Costamagna D., Scuderi S., Vaira M., Barone R., De Simone M. Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy // Tumori. 2003. — Vol.89, № 4. — P.40−42.
- Dahl 0., Dalene R., Schem B.C., Mella 0. Status of clinical hyperthermia // Acta Oncol. 1999. — Vol. 38. — P. 863−873.
- Deraco M., Santoro N., Carraro O. Peritoneal carcinomatosis: feature of dissemination. A review. // Tumori. 1999. — Vol. 85, № 1. — P. 1−5.
- Deraco M., Raspagliesi F., Kusamura S. Management of peritoneal surface component of ovarian cancer // Surg. Oncol. Clin. N. Amer. -2003. Vol.12, № 3. — P.561−583.
- Doglietto G.B., Pacelli F., Caprino P. Surgery: independent prognostic factor in curable and far advanced gastric cancer // World J. Surg. -2000. Vol. 24, № 4. — P. 459 — 463.
- Dudar Т.Е., Jain R.K. Differential response of normal and tumour microcirculation to hyperthermia // Cancer Res. — 1984. Vol. 44. — P. 605−612.
- Dukes C.E., Bussey H.R. The spread of rectal cancer and its effect on prognosis // Brit. J. Cancer. 1958. — Vol. 12. — P. 309−320.
- Elias D., Detroz В., Debaene B. Treatment of peritoneal Carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts // Hepatogastroenterology. 1994. — Vol. 41. — P. 207−213.
- Elias D., Damia E., Puizillout J. Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis // Reg. Cancer Treat. 1996. — Vol. 9. — P. 54−59.
- Elias D. M., Ouellet J. F. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results // Surg. Oncol. Clin. N. Amer. 2001. Vol. 10, № 4.-P. 915−33.
- Elias D., Blot F., Otmany A., Antoun S., Lasser P., Boige M. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy // Cancer. 2001. -Vol. 92.-P. 71—76.
- Eltabbakh G.H., Werness B.A., Piver S. Prognostic factors in extraovarian primary peritoneal carcinoma // Gynecol. Oncol. 1998. -Vol. 71, № 2.-P 230−239.
- Eisenkop S.M., Friedman RL., Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study // Gynecol. Oncol. 1998. -Vol. 69,№ 2.-P 103−108.
- ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of ovarian cancer // Ann. Oncol. 2001. — Vol. 12. — P. 1205−1207.
- Esquivel J., Sugarbaker P.H. Second-look surgery in patients with peritoneal dissemination of appendiceal malignancyranalysis of prognostic factors in 98 patients // Ann. Surg. 2001. — Vol. 234. -P. 198−205.
- Fernandez-Trigo V., Stuart O.A., Stephens A.D. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin С // Cancer Treat. Res. 1996. — Vol. 81. — P. 51 -61.
- Fong Y., Salo J. Surgical therapy of hepatic colorectal metastasis // Semin. Oncol.—1999.—№ 5.—P. 514−523.
- Francis P., Rowinsky E., Schneider J., Hakes Т., Hoskins W., Markman M. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study // J. Clin. Oncol. -1995. Vol. 13. — P. 2961 — 2967.
- Fujimoto S., Shrestha R.D., Kokubun M. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer // Ann. Surg. 1989. — Vol.212, № 5. — P.592−596.
- Fujimoto S., Shrestha R.D., Kokubun M. Clinical outcome of combined therapy of intraoperative hyperthennochemotherapy and surgery forpatients with peritoneal recurrence from gastric cancer // Reg. Cancer Treat. 1990. — Vol.3. — P.181−184.
- Fujimoto S., Kobayashi K., Takahashi M. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia // Brit. J. Cancer. 1992. — Vol. 65. — P. 33−36.
- Fujimoto S., Zhang В., Minami S., Wang X., Takahashi Y., Mai M. Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma // Oncology. 2002. — Vol. 62, № 3. p. 201−208.
- Fujimura Т., Yonemura Y., Fushida S. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination, in gastric cancers and subsequent second-look operation // Cancer. 1990. — Vol.65. -P.65−71.
- Fujimara Т., Yonemura Y., Muraoka K. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study // World J. Surg. 1994. -Vol.18.-P.150−155.
- Fujimura Т., Yonemura Y., Fujita H., Michiwa Y., Kawamura Т., Nojima N. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies // Int. Surg. -1999.-Vol. 84. P.60−66.
- Fujimura Т., Kinami. S., Ninomiya I., Kitagawa H., Fushida S., Nishimura G., Kayahara M., Shimizu K., Ohta Т., Miwa K. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer // Endoscopy. -2002. Vol. 34, № 7. — P. 569−574.
- Fuzun M., Elverdi В., Avci G. Cytoreductive approach to peritoneal carcinomatosis from adenocarcinoma of the large bowel (report of 8 cases) // Reg. Cancer Treat. -1996−1998. Vol. 9. — P.223−226.
- Gilly F.N., Carry P.Y., Sayag A.C., Brachet A., Panteix G., Salle B. Regional chemotherapy and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis // Hepatogastroenterology. -1994.-Vol.41.-P.124−129.
- Glehen O., Beaujard A.C., Arvieux C., Huber O., Gilly F.N. Les carcinoses peritoneales. Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia. // Gastroenterol. Clin. Biol. -2002. Vol.26, № 3. — P.210−215.
- Gomez P.A. Sugarbaker P.H., Chang D. Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features // World J. Surg. 1999. — Vol.23. — Vol.23−29.
- Green S., Weiss G.R. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria // Invest. New Drugs. -1992.-Vol. 10.-P. 239−253.
- Griffiths C.T., Parker L., Lee S., Finkler N.J. The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: long-term results // Int. J. Gynecol. Cancer. -2002.-Vol. 12, № 4.-P. 323−331.
- Guichard S., Chatelut E., Lochon I. Comparison of the pharmacokinelics and efficacy of irinotecan after administration by intravenous versus intraperitoneal route in mice // Cancer Chemother. Pharmacol. 1998. — Vol.42. — P.165−170.
- Gulec S.A., Mountcastle T.S., Frey D., Cundiff J. D., Mathews E., Anthony L., O’Leary J.P., Boudreaux J.P., Cytoreductive surgery in patients with advanced-stage carcinoid tumors // Amer. Surg. 2002. -Vol. 68, № 8.-P. 667−71.
- Hahn G.M., Strands D.P. Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells // J. Natl. Cancer Inst. -1976. — Vol.57. -P.1063−1067.
- Hamazoe R., Maeta M., Kaibara N. Intraoperative thermochemotherapy for prevention of peritoneal recurrence of gastric-cancer. Final results of a randomized controlled study // Cancer. 1994. — Vol.73. — P.2048−2052.
- Hayes N., Wayman J., Wadehra V., Scott D.J., Raimes S.A., Griffin S.M. et al. Peritoneal cytology in the surgical evaluation of gastric carcinoma. // Brit. J. Cancer. -1999. Vol. 79, № 3−4. — P. 520−524.
- Hermans J., Bonenkamp J.J. Boon M.C. Adjuvant chemotherapy after curative resections for gastric cancer: Meta-analysis of randomised trials //J. Clin. Oncol. 1993. — Vol. 11. — P. 1441 — 1447.
- Hinson F. L., Ambrose N. S. Pseudomyxoma peritonei // Brit. J. Surg. -1998.-Vol.85.-P. 1332−1339.
- Howell S.B., Pfeifle C.L., Wung W.E., Olshen R.A., Lucas W.E., Yon J.L. Intraperitoneal cisplatin with systemic thiosulfate protection // Ann. Intern. Med. 1982. — Vol. 97. — P. 845 — 851.
- Hunter W.R., Alexander N.D.E., Soutter W.P. Meta-analysis of surgery in advanced ovarian cancer: is maximum cytoreductive surgery an independent determinant of prognosis? // J. Obstet. Gynecol. 1992. -Vol. 166. -P.504−511.
- Huober J., Meyer A., Wagner U. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer // J. Cancer Res. Clin. Oncol. 2002. — Vol. 128, № 3. — P. 153−60.
- Ikeguhi M., Kondou O., Oka A. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion // Europ. J. Surg. 1995. — Vol. 161. — P. 581−586.
- Isozaki H., Okajima K., Kawashima Y., Yamada S. Relative noncurative resection of gastric cancer: a review of 106 cases // Jpn J Cancer Clin. -1993. Vol.39, № 6. — P.657−662.
- Jacquet N. New philosophy in the treatment of peritoneal carcinomatosis of gastrointestinal origin // Bull. Mem. Acad. R. Med. Belg. -1998. Vol.153, № 10−11. — P. 414−425.
- Jacquet P., Sugarbaker P.H. Peritoneal-plasma barrier // Cancer Treat. Res. 1996. — Vol.82. — P. 53−63.
- Jacquet P., Averbach A., Stuart O.A., Chang D., Sugarbaker P.H. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model // Cancer Chemother. Pharmacol. 1998. — Vol.41.- P. 147−154.
- Jahne J., Piso P. Peritonektomie und intraperitoneale Chemotherapie -Neue Wege zur multimodalen Therapie der Peritonealkarzinose // Langenbecks Arch. Chir. 1998. — Bl. 115. — S. 1435−1437.
- Japanese Classification of Gastric Cancer — 2nd Engl. -Edit. / Japanese Gastric Cancer Association // Gastr. Cancer. — 1998. — Vol. 1.- P. 1024.
- Jayne D. G., Fook S., Lot C., Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer // Brit. J. Surg. 2002. — Vol. 89, № 12. — P. 1545−1551.
- Jeung H. C., Rha S. Y., Jang W. I., Noh S. H., Chung H. C. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy // Brit. J. Surg. -2002. Vol. 89, № 4.- P. 460−466.
- Jivan S., Bahal V. Pseudomyxoma peritonei // Postgrad. Med. J. 2002.- Vol. 78, № 917. — P. 170−2.
- Kaibara N., Litsuka Y., Kimura A. et al. Relationship between area of serosal invasion and prognosis in patients with gastric cancer // Cancer. -1989. -Vol. 60. P.136−139.
- Kaplan E.L., Meier P. Nonparametic estimation from incomplete observations // J. Amer. Stat. Assoc. 1958. — Vol.53 — P. 457−60.
- Katai H., Maruyama K., Sasako M. Mode of recurrence after Gastric Cancer Surgery // Digestive Surgery. 1994.-Vol. 11.- P. 99−103.
- Kelsen D.P. Adjuvant and neoadjuvant therapy for gastric cancer // Semin. oncol. — 1996. Vol. 23, № 3. — P. 379−389.
- Kikuchi S., Arai Y., Morise M. Gastric cancer with metastases to the distant peritoneum: A 20-year surgical experience // Hepatogastroenterology. -1998.- Vol.45. -P.l 183−1188.
- Kitani K., Morimoto Т., Shibata N. Effects of intraperitoneal injection of low-dose CDDP on 3 patients with ascites owing to peritonitis carcinomatosa of gastric and colorectal carcinoma. // Gan-To-Kagaku-Ryoho. 2001. — Vol. 28, № 11. — P. 1666−1668.
- Kitagawa Т., Ku Y., Saitoh Y. An experimental study on liver hyperthermia using intraperitoneal hyperthermic perfusion (IPHP). // Gan-To-Kagaku-Ryoho. 1994. — Vol. 21, № 13. -P. 2295−2297.
- Kiyasa K., Kaneshima S., Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer // Cancer Res. 1981. — Vol. 41. — P. 1236−1239.
- Koga S., Hamazoe R., Maeta M. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin-C // Cancer. 1988. — Vol.61. — P. 232−237.
- Kristensen G.B. Cytoreduction in ovarian cancer // Lancet. 1997. -Vol. 349. — P.13−18.
- Kunisaki C., Shimada H., Nomura M. Does continuous hyperthermic peritoneal perfusion have any prophylactic or therapeutic efficacy on peritoneal dissemination of gastric cancer?: 4th International gastric cancer congress. New York, 2001. — P.31.
- Kuzuya Т., Yamauchi M., Ito A. Pharmacokinetic characteristics of 5-nuorouracil and mitomycin С in intraperitoneal chemotherapy // J. Pharm. Pharmacol. 1994. — Vol.46. — P. 685−689.
- Langenhoff B. S., Krabbe P. F. M., Wobbes Т., Ruers T. J. M. Quality of life as an outcome measure in surgical oncology // Brit. J. Surg. -2001. Vol. 88, № 5. — P.643−652.
- Lawrence W., McNeer G. The effectiveness of surgery for palliation of incurable gastric cancer // Cancer. 1958. — Vol.1, № 1. — P. 23−32.
- Litsuka Y., Kakeshima S., Tanida 0. Intraperitoneal free cancer cells and their viability in gastric cancer // Cancer (Philad.). — 1979. Vol. 44. -P. 1476- 1481.
- Litsuka Y., Matsui Т., Hiraoka Y. Prognosis of gastric cancer in relation to the square of serosal invasion // Jpn. J. Cancer Clin. 1987. -Vol. 33, № 3. — P.273 — 277.
- Look M., Chang D., Sugarbaker P.H. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum // Int. J. Gynecol. Cancer. 2003. — Vol.13, № 6. — P.764−770.
- Loggie B.W., Fleming R.A. Complications of heated intraperitoneal chemotherapy and strategies for prevention // Peritoneal canceromatosis:
- Principles of management Ed by P.H. Sugarbaker. New York: Kluwer Academic Publishers- Boston.- 1996. — P.221−233.
- Loggie B.W., Fleming R.A., Mcquellon R.P., Russell G.B., Geisinger K. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin // Amer. Surg. 2000. — Vol. 66. — P.561−568.
- Loggie B. W., Fleming R.A., McQuellon R.P., Russell G. В., Geisinger K.R. and Levine E. A. Prospective trial for the treatment of malignant peritoneal Mesothelioma // Amer. Surg. 2001. — Vol. 67, № 10. -P.999−1004.
- Los G., McVie J.G. Experimental and clinical status of intraperitoneal chemotherapy // Europ. J. Cancer. 1990. — Vol. 26. — P.755 -762.
- Lukacs G., Garami Z., Kanyari Z., Hajdu J. Surgical treatment of gastric cancer, a retrospective study with special reference to epidemiology //Acta Chir. Hung. 1997. — Vol. 36, № 1−4. — P. 207−209.
- Machover D. A comprehensive review of 5-nuorouracil and leucovorin in patients with metastatic colorectal carcinoma // Cancer. 1997. — Vol. 80. -P.l 179−1187.
- Malheiros C.A., Salgueiro L. Т., Ilias E.J. Palliative gastrectomy: Is it worth it?: Proceeding of the 4th International Gastric Cancer Congress. New-York, USA, 2001.-P.291.
- Maehara Y., MoriguchiS., Kakeji Y. Patient risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis // Surg. 1991. — Vol. 110. — P. 820- 823.
- Maekawa S., Saku M., Maehara Y., Sadanaga N., Ikejiri K., Anai H., Kuwano H., Sugimacni K. Surgical treatment for advanced gastric cancer // Hepatogastroenterology. 1996. — Vol. 43. — P. 178−186.
- Mainwaring P. Hepatic resection for colorectal cancer: medical oncologist’s view // Book of Abstracts. 11th International Congress of Anticancer Treatment.— 2001.- P. 121−127.
- Marayama M., Nagahama Т., Yuasa Y. Intraperitoneal versus intravenous CPT-11 for peritoneal seeding and liver metastasis // Anticancer Res. 1999. — Vol.19. — P. 4187−4191.
- Mari E., Floriani I., Tinnav A. Efficacy of adjuvant chemotherapy after curative resections for gastric cancer: A meta-analysis of published randomised trials // Ann. Oncol. 2000. — Vol. 11. — P. 837- 843.
- Markman M. Intraperitoneal chemotherapy // Semin. Oncol. 1991. -Vol.18.-P.248−254.
- Markman M. Intraperitoneal chemotherapy of ovarian cancer // Semin. Oncol. -1998. Vol.25. — P. 356−360.
- Markman M., Brady M.F., Spirtos N.M., Hanjani P., Rubin S.C. Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study // J. Clin. Oncol. 1998. -Vol. 16.-P. 2620 -2624.
- Marcus E.A., Weber Т.К., Rodriguez-Bigas M.A., Driscoll D., Meropol N.J., Petrelli N.J. Prognostic factors affecting survival in patients with colorectal carcinomatosis // Cancer Invest. 1999. — Vol.17, № 4. — P. 249−252.
- Mari E., Floriani I., Tinnazi A. Efficacy of adjuvant chemotherapy after curative resections for gastric cancer: A meta-analysis of published randomised trials // Ann. Oncol. 2000.- Vol. 11. — P. 837−843.
- Maruyama K., Sasako M., Kinoshita Т., Okajima K. Efectiveness of systemic lymph node dissection in gastric cancer surgery // Nishi M., 1. hikawa H. et al. (ed). Gastric Cancer. Tokyo: Springer, 1993. — P. 293 — 305.
- Martin V.R. Ovarian cancer // Semin. Oncol. Nurs. 2002. — Vol. 18, № 3.-P. 174−183/
- McGuire W.P., Hoskins W.J., Brady M.F. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer // N. Engl. J. Med. 1996. — Vol. 334. -P. 1−6.
- McQuellon R.P., Loggie B.W., Fleming R.A., Russell G.B., Lehman A.B., Rambo T.D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis // Europ. J. Surg. Oncol. 2001. — Vol. 27, № 1. — P. 65−73.
- McVie J.G., Dikhoff Т., Van der Heide J. Tissue concentration of platinum after intraperitoneal cisplatinum administration in patients // Proc. Amer. Assoc. Cancer Res. 1985. — Vol.26. — P. 162−163.
- Midgley R. Ken D. Colorectal cancer // Lancet. 1999. -Vol.353. — P. 391−399.
- Minsky B.D., Mies C., Rich T.A. Potential curative surgery of colon cancer: patterns of failure and survival // J. Clin. Oncol. 1988. — Vol.6.- P.106−108.
- Monson R.T., Donohue J.H., Mcllrath D.C. Total gastrectomy for advanced cancer A worthwhile palliative procedure // Cancer. — 1991. — Vol. 68. P. l863−1868.
- Moriguchi S., Maehara Y., Korenaga D., Sugimachi K. Risk factor which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer // Surg. Oncol. 1992. — Vol. 1. — P.341−346.
- Murphy P., Alexander P., Fleming J., Taylor I. Patternof spread of bloodborne tumour // Brit. J. Surg. 1986. — Vol.73. — P.829−834.
- Nakamura K. Histogenesis of gastric carcinoma and its clinicopathological significience // Nishi M., Ichikawa H. (ed). Gastric Cancer. Tokyo: Springer, 1993.-P 112−132.
- Nakai K., Nakane Y., Kanbara T. Prognostic value of peritoneal washing cytology with positive findings for gastric cancer: 4th International gastric cancer congress. New York, 2001. — P.392.
- Ng E. K.V. Chan A.C.W., Chu W. Should palliative gastrectomy be performed for patients with peritoneal metastasis from an asymptomatic gastric cancer?: Proceeding of the 4th international Gastric Cancer Congress. New- York, USA, 2001. — P. 292.
- Noh S.H., Son B.H., Min J.S. Treatment of gastric cancer with peritoneal metastasis // J. Korean Surg. Soc. 1995. — Vol. 49. — P. 7783.
- Ohno S., Siddik Z.H., Baba H., Stephens L.C., Strebel F.R., Wondergem J. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats // Cancer Res. 1991. -Vol. 51. — P. 2994- 3000.
- Ohno S., Moehara Y., Ohiwa H. Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach // Semin. Surg. Oncol. 1994. — Vol. 10.- P. l 17−120.
- Okada M., Kojima S., Murakami M. Human Gastric Carcinoma: Prognosis in relation to macroscopic and microscopic features of the primary tumour // J. Nat. Cancer Inst. -1983. Vol. 71. — P.275−279.
- Otsuji E., Yamaguchi Т., Sawai K., Okamoto K., Takahashi T. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma // Brit. J. Cancer. 1999. -Vol. 79, № 11−12. — P. 1789−1793.
- Ouchi K., Sucawara Т., Ono H. Therapeutic Significance of Palliative Operations for Gastric Cancer for Survival and Quality of Life // J. Surg. Oncol. 1998. — Vol.69. — P.41−44.
- Ozols R.F., Locker G.Y., Doroshow J.H. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer // Cancer Res. 1979. — Vol.39. — P.3209−3214.
- Panici P., Landoni F., Scarabelli S. Systematic pelvic and para-aortic lymphadenectomy versus resection of only palpable lymph nodes in optimal cytoreduction // Int. J. Gynecol. Oncol. 1999. — Vol. 9. — P. 26.
- Panteix G., Guillaumont M., Cherpin L. Study of the pharmakokinetics of mitomycin С in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues // Oncology. -1993.-Vol.50.-P.366−370.
- Park В.J., Alexander H.R., Libutti S.K., Wu P., Royalty D., Kranda K.C. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP) // Ann. Surg. Oncol. 1999. -Vol. 6. -P.582−590.
- Pestieau S.R., Sugarbaker P.H. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant, delayed management // Dis. Colon Rectum. 2000. — Vol. 43. — P.1341−1346.
- Pestieau S.R., Stuart O.A., Sugarbaker P.H. Multi-targeted antifoiate (MTA): Pharmacokineucs of inlraperitoneal administration in a rat model // Europ. J. Surg. Oncol. 2000. — Vol.26. — P.696−700.
- Piso P., Bektas H., Werner X. Improved prognosis following peritoneotomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma // Europ. J. Surg. Oncol. 2001. — Vol.27. — P.286−290.
- Portilla A.G., Sugarbaker P.H., Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features // World J. Surg. -1999. Vol. 23, № 1. — P 23−29.
- Preusser P, Wilke H, Achterrath W. Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer //J. Clin. Oncol. 1989. — Vol.7, № 9. — P. 1310−1317.
- Robins H.I., Cohen J.D., Schmitt C.L., Tutsch K.D., Feierabend C., Arzoomanian R.Z. Phase I clinical trial of carboplatin and 41,8°C whole-body hyperthermia in cancer patients // J. Clin. Oncol. 1993. -Vol. 11.-P. 1787- 1794.
- Ronnett B.M., Shmookler B.M., Sugarbaker P.H. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary // Anat. Pathol. 1997. — Vol.2. — P. 197−226.
- Rossi C.R., Mocellin S., Pilati P., Foletto M., Quintieri L., Palatini P., Lise M. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin // Surg. Oncol. Clin. N. Amer. -2003. Vol.12, № 3. — P.781−94.
- Rubin J., Jones Q., Planch A., Bower J.D. The minimal importance of hollow viscera to peritoneal transport during peritoneal dialysis in the rat // Amer. Soc. Artif. Intern. Organs Transact. 1988. — Vol.34. — P.912−915.
- Rubin S.C., Randall T.C., Armstrong K.A., Chi D.S., Hoskins W.J. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings // Obstet. Gynecol. 1999. — Vol. 93, № 1.-P 21−24.
- Sadeghi В., Arvieiix C., Glehen O., Beaujard A.C., Rivoive M., Baulieux J. Peritoneal carcinomatosis from non-gynecologic malignancies results of the EVOCAPE 1 multicentric prospective study // Cancer. 2000. — Vol. 88. — P. 358−363.
- Sampson J. A. Implantation peritoneal carcinomatosis of ovarian origin // Amer. J. Pathol.-1931.-Vol.7.-P.423−443.
- Sayag-Beuajard A.C., Francois Y., Glehen 0., Sadeghi-Looyeh В., Bienvenu J., Panteix G. Intraperitoneal hemohyperthermia withmitomycin С for gastric cancer patients with peritoneal carcinomatosis // Anticancer Res. 1999. — Vol.19. — P. 1375−1382.
- Schneider U. Klassifizierung der Peritonealkarzinose und deren Abgrenzung vom Pseudomyxoma peritonei // Kongressbd.-Dtsch.-Ges.-Chir.-Kongr. 2001. — Bl. l 18. — S.205−208.
- Schnake K.J., Sugarbaker P.H., Yoo D. Neutropenia following perioperative intraperitoneal chemotherapy// Tumori. 1999. — Vol. 85, № 1. — P 41−46.
- Schneebaum S., Arnold M. W., Staubus A., Young D. C., Dumond D., Martin E. W. Intraperitoneal Hyperthermic Perfusion with Mitomycin С for Colorectal Cancer with Peritoneal Metastases // Ann. Surg. Oncol. -1996. Vol. 3,№ 1.- P. 44−50.
- Scuderi S., Costamagna D., Vaira M., Barone R., De Simone M. Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy // Tumori. 2003. — Vol.89, № 4. — P.43−45.
- Sebbag J., Yan H., Shmookler B.M. Results of treatment of 33 patients with peritoneal mesothelioma // Brit. J. Surg. 2000. — Vol.87. — P. 1587−1593.
- Shido A., Ohmura S., Yamamoto K. Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion // World J. Surg. 2000. — Vol.24. — P.507−511.
- Shigeoka H., Okuno K., Tanaka A. Adjuvant perioperative intraperitoneal chemotherapy for highrisk gastric cancer: Result of randomized clinical trial: 4th International gastric cancer congress. -New York, USA, 2001. P.439
- Shime N., Lee M., Hatanaka T. Cardiovascular changes during continuous hyperthermic peritoneal perfusion // Anesth.-Analg. 1994. — Vol. 78, № 5. -P. 938−942.
- Shiu M.H., Fortner J.G. Treatment of implanted peritoneal canceromatosis in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug // Cancer Res. 1980. — Vol. 44. -P. 4081−4084.
- Siewert J.R., Fink U., Sendler A. Gastric cancer // Curr. Probt. Surg. -1997.-Vol.34.-P. 838−939.
- Siewert J.R. Treatment strategy of locally advanced gastric cancer: Plenary lecture in the scientific program of the 3rd International Gastric Cancer Congress. Seoul, Korea, 1999. — P. 342.
- Solomon M.J., Egan M., Roberts R.A. Incidence of free-colorectal cancer cells on the peritoneal surface // Dis. Colon Rectum. 1997. -Vol.40.-P. 1294−1298.
- Soudan В., JahneJ., Maschek H. Freie Tumorzellen in praoper-ativen Periloneallavagen bei Patienten mil Magen Karzinomen // Zbl. allg. Pathol und pathol. Anal. 1989. — Vol. 135, № 2. — P.183 — 187.
- Speyer J.L., Sugarbaker P.H., Collins J.M. Portal levels and hepatic clearance of 5-nuorouracil after intraperitoneal administration in humans // Cancer Res. 1981. — Vol.41. — P.1916−1922.
- Speyer J.L. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies // Semin Oncol. 1985. — Vol.12. — P. 2328.
- Spratt J.S., Adcock R.A., Shirrell W., Trevathan S. Hyperthermic peritoneal perfusion system in canines // Cancer Res. 1980. — Vol.40. -P.253−254.
- Spratt J.S., Adcock R.A., Muscovin M., Shinell W., McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy // Cancer Res. 1980. — Vol. 40. — P.25 6−260.
- Spratt J.S., Edwards M., Kubota Т., Linberg R., Tseng M.T. Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, management // Curr. Probl. Cancer. 1986. — Vol. 10. — P.558−584.
- Storm F.K. Clinical hyperthermia and chemotherapy // Radiol. Clin. Nam. 1989. — Vol.27. — P.621−627.
- Stuart O.A., Stephens A. D., Welch L., Sugarbaker P.H. Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin С // Ann. Surg. Oncol. -2002. Vol. 9, № 2. -P. 186−91.
- Sugarbaker P. H. Management of Peritoneal Carcinomatosis // AMA. -1989.-Vol.16.-P.57−60.
- Sugarbaker P.H. Peritonectomy procedures // Ann. Surg. 1995. — Vol. 221.-P. 29−42.
- Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery: Manual for Physicians and Nurses Washington Cancer Institute. Washington: The Ludann Company Grand Rapids, 1998. — 40 p.
- Sugarbaker P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis // Semin. Surg. Oncol. 1998. — Vol.14. — P.254−261.
- Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer // Cancer Chemother. Pharmacol. 1999. -Vol.43.-P.15−25.
- Sugarbaker P. H. Management of peritoneal-surface malignancy: the surgeon’s role // Langenbecks Arch. Surg. 1999. — Vol.384. — P.576−587.
- Sugarbaker P.H., Yonemura Y. Clinical pathway for the management of respectable gastric cancer with peritoneal seedings: best palliation with a ray of hope for cure // Oncology. 2000. — Vol. 58. — P.96−107.
- Sugarbaker P.H. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome // Tumori. 2001. — Vol. 87, № 4. — P. 3−5.
- Sugarbaker P.H. Vertical abdominoplasty // J. Surg. Oncol. -2001. -Vol.78, № 3.-P. 217−219.
- Sugarbaker P. H., Yan H., Shmookler B. Pedunculated peritoneal surface polyps in pseudomyxoma peritonei syndrome // Histopathology. 2001. — Vol. 39, № 5. — P.525−528.
- Sugarbaker P.H. Cytoreduction including total gastrectomy for pseudomyxoma peritonei // Brit. J. Surg. 2002.-Vol. 89, № 2. — P. 208−212.
- Sugarbaker P.H., Acherman Y.I., Gonzalez-Moreno S. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience // Semin. Oncol.- 2002 Vol. 29, № 1.- P. 51−61
- Suzuki M., Ohwada M., Sekiguchi I. Radical cytoreductive surgery with platinums carboplatin and cisplatin chemotherapy for advanced ovarian cancer // Int. J. Gynecol. Cancer. — 1999. — Vol. 9. — P. 54−60.
- Тау Е.Н., Grant Р.Т., Gebski V., Hacker N.F. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer // Obstet. Gynecol. -2002. Vol.99, № 6. — P.1008−1013.
- Tong D., Russell A.H., Dawson L.E. Adenocarcinoma of the cecum: natural history and clinical patterns of recurrence following radical surgery // Int. J. Radial. Oncol. Biol. Phys. 1983. — Vol. 9. — P. 357 360.
- Toung R.C. Management of ovarian cancer // Sem. Oncol. 1998. -Vol. 25.-P. 335−338.
- Tsiftsis D., de Bree E., Romanos J., Petrou A., Sanidas E., Askoxylakis J., Zervos K., Michaloudis D. Peritoneal expansion by artificially produced ascites during perfusion chemotherapy // Arch. Surg. 1999. -Vol.134, № 5.-P. 545−549.
- Uthman I.W., Bizri A.R., Khalifeh M.J. Peritoneal sarcoidosis // Semin. Arthritis. Rheum. -2002. Vol. 31, № 5. — P. 353.
- Velanovich V. Staging laparoscopy in the management of intraabdominal malignancies // Surgery. 1998. — Vol. 124, № 4. — P 773−80.
- Vergote I., De Wever I., Tjalma W. et al. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients // Gynecol. Oncol. -1998. Vol. 71,№ 3.-P. 431−436.
- Verwaal V.J., van Tinteren H., Ruth S.V., Zoetmulder F.A. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy // J. Surg. Oncol. 2004. — Vol.85, № 2. — P.61−67.
- Vong R., De Cosse J. Cytoreductive surgery // Gynecology et Obstetrics. 1990. — Vol. 170. — P. 276−280.
- Watanabe M., Tanaka R., Hondo H. Effects of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells // Int. J. Hypertherm. 1992. — Vol.8. — P. 131−138.
- Weis L. Principles of Metastasis. Orlando: Academic Press, 1985. — 52 P
- Weis L. Theory of metastasis insufficiency: causes and consequences // Can. Rev. 1986. — Vol. 3. — P. 1−24.
- Weisberger A.S., Levine В., Storaasli J.P. Use of nitrogen mustard in treatment of serous effusions of neoplastic origin // JAMA. 1955. -Vol.159.-P. 1704−1707.
- Witkamp J., de Bree E., Van A. R. Zoetmulder Rationale and techniques of infra-operative hyperthermic intraperitoneal chemotherapy // Cancer Treatment Reviews. 2001. — Vol. 27. — P. 365−374.
- Wydra D., Emerich J. Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer. // Ginekol. Pol. 2002. -Vol.73,№ 11. -P.1044−1047.
- Yonemura Y., Fujimura Т., Fushida S. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination // World J. Surg. 1991. — Vol. 15. — P. 530−536.
- Yonemura Y., Ninomiya I., Kaiji M., Sugiyama K., Fujimura K., Sawa T. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer // World J. Surg. 1995. — Vol. 19. — P. 450−455.
- Yonemura Y., Fujimura Т., Fushida S. Techniques of peritonectomy forLadvanced gastric cancer with peritoneal dissemination: Proceedings of the 2 International Gastric Cancer Congress. Munich, Germany, 1997. — P. 226 -232.
- Yonemura Y., Fujimura Т., Fushida S., Fujita H., Bando E., Nishimura G. A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination // Hepatogastroenterology. 1999. — Vol. 46, № 25. — P. 601- 609.
- Yonemura Y. A new treatment strategy for peritoneal dissemination peritonectomy intraoperative chemo-hyperthermia, and EPIC: 4th International gastric cancer congress: New York, USA, 2001. P.335.
- Yonemura Y., Bandou E., Kinoshita K., Kawamura Т., Takahashi S., Endou Y., Sasaki T. Effective therapy for peritoneal dissemination in gastric cancer // Surg. Oncol. Clin. N. Amer. 2003. — Vol.12, № 3. — P. 635−48.
- Yoo C.H., Noh S.H., Shin D.W. Early postoperative intraperitoneal chemotherapy (EPIC) for advanced gastric cancer: 3rd International gastric cancer congress. Seoul, Korea, 1999. — P. 103.
- Yu W., Whang I., Averbach A. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer // Amer. Surg. 1998. — Vol. 64, № 11. — P. 1104−1108.
- Yu W., Chung H.Y., Averbach A. Indications for early postoperative intraperitoneal chemotherapy in advanced gastric cancer: Third Int Gastric Cancer Congr. Seoul, 1999. — P.99.
- Yu W., Whang I, Chung H. Y., Averbach A., Sugarbaker P.H. Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial // World J. Surg. 2001. — Vol. 25. — P. 985−990.
- Yu W., Seo B. Y., Chung H. Y. Postoperative body-weight loss and survival after curative resection for gastric cancer // Brit. J. Surg. -2002.-Vol. 4.-P. 467−470.
- Zakris E.L., Dewhirst M.W., Riviere J.E., Hoopes P.J., Page R.L., Oleson J.R. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia // J. Clin. Oncol. 1987. — Vol. 5. — P.1613−1620.
- Zaffaroni N., Villa R., Orlandi L. Effects of hyperthermia on the formation and removal of WA interstrand cross-links induced by melfalan in primary cultures of human malignant melanoma // Int. J. Hyperthermia. 1992. — Vol. 8. — P. 341−349.
- Zeamari S., Floot В., van der Vange N., Stewart F.A. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC) // Anticancer Res. 2003. -Vol.23, № 2.-P. 1643−1648.
- Zim S., Clear S.M., Lucas W.E. Phase I pharmacokinetics study of intraperitoneal cisplatin and etoposide // Cancer Res. 1987. -Vol.47. -P.l 712−1716.